Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaypd CeuticalNSE:VIJAYPD -3.13%11 ROC (Joel Greenblatt) % is 16.56% as of Mar. 2026, which is 27% below its 10-year median of 22.74. GuruFocus rates NSE:VIJAYPD with a GF Score™ of 11/100. The stock has 6 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Vijaypd Ceutical ranks worse than 56.59% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Vijaypd Ceutical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 16.56%.
The historical rank and industry rank for Vijaypd Ceutical's ROC (Joel Greenblatt) % or its related term are showing as below:
NSE:VIJAYPD'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 8.28 Med: 22.74 Max: 28.1
Current: 8.28
During the past 4 years, Vijaypd Ceutical's highest ROC (Joel Greenblatt) % was 28.10%. The lowest was 8.28%. And the median was 22.74%.
NSE:VIJAYPD's ROC (Joel Greenblatt) % is ranked worse than 56.59% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 12.515
vs NSE:VIJAYPD: 8.28
Vijaypd Ceutical's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Vijaypd Ceutical ROC (Joel Greenblatt) % Related Terms
Vijaypd Ceutical ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Vijaypd Ceutical's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Vijaypd Ceutical's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaypd Ceutical ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vijaypd Ceutical's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Vijaypd Ceutical's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 16.56% mean?
Vijaypd Ceutical (NSE:VIJAYPD) has a ROC (Joel Greenblatt) % of 16.56% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Vijaypd Ceutical and its competitors. This is 27% below median its historical median of 22.74. Over the past decade, Vijaypd Ceutical's ROC (Joel Greenblatt) % has ranged from 8.28 to 28.10. According to the industry distribution chart, Vijaypd Ceutical ranks #378 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 56.6%.
Is Vijaypd Ceutical's ROC (Joel Greenblatt) % too high?
Vijaypd Ceutical's current ROC (Joel Greenblatt) % of 16.56% is 27% below median its 10-year median of 22.74. Over the past 10 years, this metric has ranged from a low of 8.28 to a high of 28.10. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.52. Vijaypd Ceutical's value of 16.56% is 32.3% above this industry median. Based on the distribution chart, Vijaypd Ceutical ranks #378 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Vijaypd Ceutical has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Vijaypd Ceutical's ROC (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Vijaypd Ceutical ranks #378 out of 668 companies for ROC (Joel Greenblatt) %. This places Vijaypd Ceutical in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 12.52. Vijaypd Ceutical's value of 16.56% is 32.3% above this benchmark. Historically, Vijaypd Ceutical's own ROC (Joel Greenblatt) % has ranged from 8.28 to 28.10 over the past decade. While the company's 10-year median is 22.74 vs. the industry median of 12.52, Vijaypd Ceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.52, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaypd Ceutical's current ROC (Joel Greenblatt) % of 16.56% is 32.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Vijaypd Ceutical and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaypd Ceutical's current ROC (Joel Greenblatt) % is 16.56%, which is 27% below median its own 10-year median of 22.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaypd Ceutical stock overvalued right now?
Vijaypd Ceutical (NSE:VIJAYPD) has a current ROC (Joel Greenblatt) % of 16.56%. The current ROC (Joel Greenblatt) % is 16.56%, which is 27% below median its 10-year median of 22.74 and 32.3% above the Healthcare Providers & Services industry median of 12.52. Vijaypd Ceutical's overall GF Score™ is 11/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Vijaypd Ceutical (NSE:VIJAYPD), the current ROC (Joel Greenblatt) % is 16.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vijaypd Ceutical Ltd is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. The company offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supply vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits.
11GF Score
Get the complete analysis for NSE:VIJAYPD
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VIJAYPD has been successfully added to your 
